Search research articles
Contact Us
Filters
Showing results (71-80 of 227) with videos related to
Page
of 23
Sort By:
Genome Announcements
|
January 31, 2015
Complete Genome Sequence of the Bioluminescent Marine Bacterium Vibrio harveyi ATCC 33843 (392 [MAV])
Zheng Wang, W Judson Hervey, Seongwon Kim, et al.
International Journal of Clinical Practice
|
July 23, 2013
Resource utilisation and quality of life following initiation of insulin detemir in patients with type 2 diabetes mellitus
A Liebl, H Andersen, A L Svendsen, et al.
Molecular and Cellular Probes
|
August 5, 2008
Comparison of detection and signal amplification methods for DNA microarrays
Gary J Vora, Carolyn E Meador, George P Anderson, et al.
Molecular Biosystems
|
August 19, 2007
Transcript and proteomic analyses of wild-type and gpa2 mutant Saccharomyces cerevisiae strains suggest a role for glycolytic carbon source sensing in pseudohyphal differentiation
Igor L Medintz, Gary J Vora, Amir M Rahbar, et al.
British Journal of Haematology
|
September 1, 1991
Polyclonal CD5 + B-lymphocytosis resembling chronic lymphocytic leukaemia
C J Lush, A J Vora, A C Campbell, et al.
Diabetologia
|
May 27, 2011
Long-term effects of insulin glargine on the risk of breast cancer
S Suissa, L Azoulay, S Dell'Aniello, et al.
BMJ (Clinical Research Ed.)
|
June 16, 2000
Cost effectiveness analysis of screening for sight threatening diabetic eye disease
M James, D A Turner, D M Broadbent, et al.
BMJ (Clinical Research Ed.)
|
October 28, 1995
Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study
S P Harding, D M Broadbent, C Neoh, et al.
British Journal of Haematology
|
August 8, 1998
Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations
D L Lancaster, L Lennard, K Rowland, et al.
Diabetes, Obesity & Metabolism
|
June 19, 2015
Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)
J Vora, N Cohen, M Evans, et al.
Page
of 23
Search research articles
Search
Showing results (71-80 of 227) with videos related to
Sort By:
Page
of 23
Genome Announcements
|
January 31, 2015
Complete Genome Sequence of the Bioluminescent Marine Bacterium Vibrio harveyi ATCC 33843 (392 [MAV])
Zheng Wang, W Judson Hervey, Seongwon Kim, et al.
International Journal of Clinical Practice
|
July 23, 2013
Resource utilisation and quality of life following initiation of insulin detemir in patients with type 2 diabetes mellitus
A Liebl, H Andersen, A L Svendsen, et al.
Molecular and Cellular Probes
|
August 5, 2008
Comparison of detection and signal amplification methods for DNA microarrays
Gary J Vora, Carolyn E Meador, George P Anderson, et al.
Molecular Biosystems
|
August 19, 2007
Transcript and proteomic analyses of wild-type and gpa2 mutant Saccharomyces cerevisiae strains suggest a role for glycolytic carbon source sensing in pseudohyphal differentiation
Igor L Medintz, Gary J Vora, Amir M Rahbar, et al.
British Journal of Haematology
|
September 1, 1991
Polyclonal CD5 + B-lymphocytosis resembling chronic lymphocytic leukaemia
C J Lush, A J Vora, A C Campbell, et al.
Diabetologia
|
May 27, 2011
Long-term effects of insulin glargine on the risk of breast cancer
S Suissa, L Azoulay, S Dell'Aniello, et al.
BMJ (Clinical Research Ed.)
|
June 16, 2000
Cost effectiveness analysis of screening for sight threatening diabetic eye disease
M James, D A Turner, D M Broadbent, et al.
BMJ (Clinical Research Ed.)
|
October 28, 1995
Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study
S P Harding, D M Broadbent, C Neoh, et al.
British Journal of Haematology
|
August 8, 1998
Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations
D L Lancaster, L Lennard, K Rowland, et al.
Diabetes, Obesity & Metabolism
|
June 19, 2015
Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)
J Vora, N Cohen, M Evans, et al.
Page
of 23